The collaboration brings together AIG Hospitals’ high-volume clinical expertise, advanced innovation capabilities, and growing artificial intelligence-led healthcare initiatives
Backed by a £680,000 grant from Leeds Hospitals Charity, the study is jointly led by academics and clinicians from the University of Leeds and Leeds Teaching Hospitals NHS Trust
The move leverages Novartis’ deep expertise in IgE biology and long-standing presence in allergic disease treatments
RSM01, a preventive treatment targeting respiratory syncytial virus (RSV), was licensed earlier this month from the Gates Medical Research Institute
The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics
The early-stage study will test the drug’s safety, tolerability and biological effects in humans
The MAST trial is designed to test whether a single dose of pre-emptive, orally administered EBX-102-02 can protect and restore microbial diversity during transplantation
Gazyva/Gazyvaro outperformed placebo across all key and secondary endpoints
The Union Budget 2026–27 accords strong priority to the upgradation and expansion of healthcare infrastructure and medical education
Projects selected for advancement will move forward through the Harvard Office of Technology Development’s processes for sponsored research agreements
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
